Simple Precision Creation of Digitally Specified, Spatially Heterogeneous, Engineered Tissue Architectures by Gurkan, Umut Atakan et al.
Simple Precision Creation of Digitally Specified, Spatially
Heterogeneous, Engineered Tissue Architectures
Umut Atakan Gurkan[+],
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Yantao Fan[+],
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Feng Xu,
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Burcu Erkmen,
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Emel Sokullu Urkac,
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Gunes Parlakgul,
Harvard Medical School, Division of Biomedical Engineering at Brigham and Women's Hospital,
Bio-Acoustic-MEMS in Medicine (BAMM) Laboratory, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Jacob Bernstein,
Media Lab and McGovern Institute, Departments of Brain and Cognitive Sciences and Biological
Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
Wangli Xing,
Medical Systems Biology Research Center, School of Medicine, Tsinghua University, Beijing
100084, PR China, National Engineering Research Center for Beijing Biochip Technology, 18 Life
Science Parkway, Beijing, 102206, P. R. China
Edward S. Boyden, and
Media Lab and McGovern Institute, Departments of Brain and Cognitive Sciences and Biological
Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Correspondence to: Wangli Xing, wlxing@tsinghua.edu.cn; Edward S. Boyden, edboyden@mit.edu; Utkan Demirci,
udemirci@rics.bwh.harvard.edu.
[+]These authors contributed equally to this work.
Supporting Information: Supporting Information is available from the Wiley Online Library or from the author.
NIH Public Access
Author Manuscript
Adv Mater. Author manuscript; available in PMC 2013 November 27.
Published in final edited form as:
Adv Mater. 2013 February 25; 25(8): . doi:10.1002/adma.201203261.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Utkan Demirci
Harvard Medical School, Brigham and Women's Hospital, Harvard-MIT Health Sciences &
Technology, 65 Landsdowne St. PRB 252, Cambridge, MA 02139, USA
Wangli Xing: wlxing@tsinghua.edu.cn; Edward S. Boyden: edboyden@mit.edu; Utkan Demirci:
udemirci@rics.bwh.harvard.edu
Natural organs are spatially heterogeneous, both in material composition and in the cell
types within. Engineered tissues, in contrast, remain challenging to create, especially if the
goal is to spatially position multiple cell types in a heterogeneous pattern in three
dimensions (3D). Here, we describe a simple, inexpensive, yet extremely precise method to
create tissue architectures in a digitally specifiable fashion, with morphological and
compositional tuning. Specifically, we pattern hydrogel crosslinking via a novel
photolithographic process that can trap solutions of extracellular matrix (ECM) components,
cells, and diffusible factors in defined 3D shapes, without requiring specialized expensive
optics or robotics. By iterating this process with different patterns and different cellular
compositions, engineered tissues of varying heterogeneity, size, and complexity can be
designed and implemented with microscale precision, in a fashion practical for individual
laboratories to perform. We demonstrate the power of this process by engineering tissue
building blocks in defined geometries, creating engineered tissues that encapsulate different
cells (e.g., primary neurons, embryonic stem cells (ESCs), human umbilical vein endothelial
cells (HUVECs), and fibroblasts) at specified locations throughout a single 3D tissue
volume. We used the ability to rapidly synthesize tissue volumes of varying scale to
examine how tissue volume governs neuron development.
Native tissues consist of multiple cell types and ECM components, which are spatially
heterogeneous and organized in a three-dimensional (3D) environment. [1–6] Precision
spatial positioning of cells and ECM components is crucial for natural tissue development
and function.[3,5,7–12,13] Engineered tissues have been difficult to generate with comparable
degrees of material and cell type spatial variability found in natural tissues. Current
technologies can pattern cells on a two-dimensional (2D) substrate, providing control over
composition and spatial arrangement on a flat surface.[14] However, cells anchored on 2D
substrates do not recapitulate important features of cell behavior in vivo, such as cell-cell
and cell-microenvironment interactions in 3D.[4–5,9–10,15,16] A current challenge is to
develop 3D tissue constructs that replicate the architecture and cellular complexity found in
vivo[2,10,15,17] for more accurate platforms for basic science, drug screening and diagnostic
platforms, and also for prototyping tissues for clinical replacement. For example, for the
brain, which has perhaps thousands of different kinds of cells, arranged in complex 3D
architecture, undamentally new kind of tissue engineering techniques might be
required.[18–22]
In recent years, many strategies have been proposed for how to define the cellular
architectures of engineered tissues in 3D,[5,23–33] but an overall technological pipeline
capable of simple, inexpensive, practical, and powerful generation of spatially varying,
micron-scale precise, and complex physiological systems, is needed. For example, existing
strategies that could be used for the creation of 3D spatially complex engineered tissues
(e.g., stereolithography, bioprinting, assembly, and casting) either do not provide degrees of
freedom in all three dimensions, essential for defining 3D spatially varying cellular
organization, or the cost and time budget rise exponentially as the resolution is pushed to
cellular scales (i.e., 10–20 μm), and as the structure dimensions are pushed to centimeter
scales–critical for creating 3D spatially varying model tissues of importance for biology and
medicine.
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To overcome these challenges, thus addressing an unmet need in 3D tissue prototyping with
microscale precision,[4,9,10,34] we created an optimized, inexpensive (～$50 material cost),
and easy-to-use version of the powerful method used in semiconductor microfabrication,[35]
multilayer photolithography, to build 3D digitally specified tissue constructs (Figure 1). The
significance of the presented approach is that it is a scalable and generalizable
biomanufacturing method with degrees of freedom in all three dimensions, with multiple-
orders-of-magnitude lower cost compared to other specialized systems (e.g.,
stereolithography devices cost tens of thousands of dollars), and allows ～10 μm precision
within and across layers offering an order-of-magnitude improvement over existing methods
without requiring expensive lithographic aligners or computerized-stage microscopes. The
key innovations include the strategy for photolithographically crosslinking hydrogels
containing cells and ECM components using multiple masks with microscale control, to
anchor them at specified coordinates in 3D space (by varying the cell and ECM
compositions before the crosslinking step, we can modulate the biological and chemical
materials being instantaneously incorporated into the engineered tissue as a function of time
and space), as well as the very simple mechanical engineering strategies utilized: since we
use simple alignment and layer-by-layer fabrication hardware, no specialized optics or
alignment systems are needed for tissue fabrication, making our method eminently
practicable in individual laboratories.
Using this platform, we developed a digitally specifiable 3D environment for brain cells, and
explored the effect of 3D spatial confinement on neural cell survival and neurite growth. We
further explored microscale engineered tissue complexity by developing prototype structures
digitally sculpted with varying cellular composition (i.e., ESCs, HUVECs, and fibroblasts)
and geometry (e.g., square, radially fractioned circular, and concentric circular), creating
tissue prototypes with a high level of precision, versatility, flexibility, and scalability. Our
work will support 3D, hierarchical, modular assembly of heterogeneous engineered tissues,
advancing the synthetic biology-driven understanding of how tissues develop and change
over time. This approach will also assist in meeting the clinical demand for replacement
tissues and organs,[36] by enabling the service of multiscale fabrication techniques in 3D,
hierarchical, modular tissue design with broad applications.
We have developed an advanced fabrication process comprising a number of digitally
controllable lithography steps (Figure 1a) to generate tissue complexity in 3D (Figure 1b).
The geometry of each and every layer is tightly controlled by predesigned photolithography
masks (Figure S1) to fabricate architectures and tissue prototypes composed of multiple
building blocks (Figure 1c–f). We have shown that complexity and organization of the
hydrogel architectures can be tightly controlled for various geometries, i.e., rectangular
prism (Figure 1f), radially fractioned circular (radial circular) (Figure 1g), concentric
circular (Figure 1h), and typescript (Figure 1i). The method utilizes a mask alignment setup
(Figure 1b and S2) to achieve high alignment precision of the building blocks (Figure S3).
We defined the alignment precision as the positioning repeatability of the centroid of the
individual building blocks during micro-fabrication based on the computer aided design
(Figure 1 and Figure S1). Alignment precision was determined (for details, see Supporting
Information) to be within: 10.9 μm (±8.2) for square geometry; 11.2 μm (±4.5) for radial
circular geometry; and 27.8 μm (±9.8) for concentric circular geometry (mean ± standard
deviation (STD), n = 16-24 measurements for each geometry).
To demonstrate the utility of this digital tissue sculpting strategy, we assessed how neuron
cell development and neurite growth could be studied in a space-constrained custom-tuned
environment. We created digitally specified neural tissues made of lithographically specified
hydrogel containing neonatal rat primary cortical neurons. We assessed neuron cell behavior
in three different hydrogel sizes, each crafted lithographically as described (100 μm × 100
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μm × 150 μm, 200 μm × 200 μm × 150 μm, 500 μm × 500 μm × 150 μm, Figure 2a). To
morphologically assess neurons in engineered tissue prototypes, we performed labeling with
anti-Tau-1 (axonal stain) and DAPI (nuclear stain), which clearly indicated the morphology
of neurites and nuclei of the cells. In each 100 μm size element, only several neurons were
encapsulated due to the space constraints, and the few cells exhibited short and undeveloped
neurites (Figure 2b–j). We observed that neurons encapsulated in 200 μm (Figure 2k–n) and
500 μm (Figure 2o–q) elements formed more elaborate 3D geometries over comparable
timescales (14 days in culture). Neurite (axon and dendrite) lengths were quantified under
comparable photopolymerization conditions in different element sizes (Figure 2r).
Specifically, neurons displayed longer neurites (p < 0.05, analysis of variance (ANOVA)
with Tukey's posthoc test for multiple comparisons) in 200 μm elements compared to 100
μm elements, which demonstrated extremely low growth. Neurons exhibited even longer
neurites in 500 μm elements (p < 0.05). Neurite growth was observed in the first three days
of culture in 100 μm and 200 μm elements, which reached a stagnant state after three days
(Figure 2r). However, in 500 μ m elements, neurite growth continued with a significant
increase compared to day 1 and day 3 (p < 0.05) till day 7, after which a significant growth
was no longer observed (p > 0.05). Projected neurite length was significantly greater (p <
0.05) in 500 μm elements than other size elements after 3 days of culture, which reached
around 800 μm in length over 14 days in culture (Figure 2r). The distribution of neurons and
their neurites in 3D was visualized using fluorescent confocal imaging (see video in the
Supporting Information). We did not observe any difference in cell survival or morphology
in different sections of the engineered constructs in 3D.
The above results suggested that neuronal growth is regulated by available volume. But
larger volume tissue cubes also contained greater numbers of neurons. Ideally one would be
able to examine effects of volume, and even 3D shape, on neural growth, independent of cell
density. Our technology enables such assessments of pure geometrical influences on neuron
growth, here demonstrated by our fabrication of complex tissue structures with a 100 μm
element touching a 500 μm element (Figure 2s) in an array (Figure 2t). In this configuration,
we selectively encapsulated single neuron cells in the 100 μm element, as enabled by our
selective photolithography, to investigate the growth of the cell whose body is localized to a
confined structure, but for which neurites are allowed to grow into a larger environment.
During the 14 day culture period, single neuron cells spatially positioned in 100 μm
elements were observed to grow towards the 500 μm element and extend neurites towards
the larger gel, resulting in a projected neurite length of 507 μm (± 103, STD, n = 7) (Figure
2u–y). Indeed, such long neurites extending into the larger 3D hydrogel compartment were
observed in all the sculpted structures analyzed (n = 7), suggesting that the neurite growth is
not only dependent on the number of cells encapsulated in a 100 μm element, but is a
function of the complex geometry of spatial confinement. Neurons appeared to be
responsive to their surroundings in a novel way, showing how our technology enables the
probing of parameters important for developmental as well as tissue engineering studies.
To gain insight into the cellular composition of the 3D neural tissue prototypes, we
identified neuronal and glial populations by staining for Tau-1 and GFAP (Figure 3a–i). The
numbers of neuronal and glial cells were statistically similar (p > 0.05, non-parametric
Mann-Whitney U test) (Figure 3j), displaying a ratio reminiscent of natural brain tissue.[37]
We observed both CaMKII- and GAD65-positive neurons indicating that both excitatory
and inhibitory neural cells were present in the 3D neural tissue prototypes (Figure 3d–i).
Excitatory neurons constituted the majority of the neurons, amounting to 83.9% (±12.6,
STD; n = 5) of the total number of neurons, similar to the fraction (i.e., 4:1 ratio of
excitatory to inhibitory) of cortical neurons in vivo that are excitatory.[38] Our results
suggested that neural networks in elements comprised a complex population of brain cells,
including excitatory neurons, inhibitory neurons, and glial cells, appearing at comparable
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ratios to that in the native rodent cortex, and highlighting the power of our technology to
preserve a diversity of brain cell types.
Photopolymerizable polymers and hydrogels (e.g., poly(ethylene glycol)/poly(L-lysine),
chitosan) have been used in combination with primary neurons, neural stem and progenitor
cells for neural tissue engineering and neural cell delivery applications.[30,39–41] In the
current study, in which we extended the power of photopolymerizable hydrogels by 3D
digital tissue sculpting, we accordingly validated the method with neuron cell viability
studies. We evaluated the effects of the duration and intensity of ultraviolet (UV) light
exposure to create photo polymerizable gelatin methacrylate hydrogels encapsulating
primary neuron cells. We first assessed the effect of light exposure duration (20, 30, and 60 s
at 2.9 mW/cm2) on cell viability (Figure 3k–m). We observed that neurons were viable after
30 seconds of light exposure applied during microfabrication. The viabilities were observed
to be 85.54 ± 7.15%, 76.10 ± 12.22%, and 22.33 ± 3.64% at 20, 30, and 60 s, respectively (n
= 3–8 samples of each kind). Sixty seconds of exposure resulted in significantly less (p <
0.05) cell viability compared to 20 and 30 seconds (Figure 3k). Therefore, results indicated
that less than 30 seconds had minimal effect (p < 0.05) on neurons with a higher viability
compared to 60 s of light exposure. Next, we assessed the effect of UV light intensity (2.9–
6.9 mW/cm2 for 20 s) on cell viability in neuron encapsulating elements (Figure 3l). We
observed no statistically significant effect (p > 0.05, n = 3) on cell viability as a result of
increasing intensity. The neuron cell viability was 83.35 ± 2.22% at an intensity of 6.9 mW/
cm2. To achieve high cell viability and minimize potential effects of UV light, we used 2.9
mW/cm2 intensity and 20 seconds crosslinking duration, which resulted in a viability of
85.54 ± 7.15%, not significantly different compared to controls that were not exposed to
light (89.24 ± 3.84%; p > 0.05; n = 3 photocrosslinked cubes, n = 3 control samples). Cell
viability assays were conducted at different time points (Figure 3m): day 0 (immediately
after photocrosslinking at 2.9 mW/cm2 intensity and 20 seconds crosslinking duration), day
3 (after 3 days of culture) and day 10. We observed similar (p > 0.05, n = 3–8) cell
viabilities at day 3 (82.82 ± 8.23%) and day 10 (89.80 ± 5.26%) compared to day 0 (85.54 ±
7.15%). These results demonstrated that the photopolymerization parameters of
photocrosslinkable hydrogels have minimal effect on neural cell viability both in short and
long term.
To demonstrate the ability to digitally sculpt complex tissues with multiple cell types, we
next created engineered 3D tissue constructs (Figure 3n) composed of three cell types
(Figure 3o), encapsulating ESCs, HUVECs and NIH 3T3 fibroblasts mimicking the
complexity in studies aiming to regenerate myocardium. [42] We observed that each cell type
was spatially confined in individual elements, as indicated by cell tracker staining (Figure
3o). We have shown that cellular composition as well as cellular concentration in each
building block can be controlled spatially (Figure 3o,p). We also observed that cells were
viable in tissue prototypes after microfabrication (Figure 3p). The quantitative viability
analysis showed that all cell types remained viable at the end of three day in vitro culture:
92% (± 5%), 74% (±8%), and 95% (± 3%) for ESCs, and 3T3s, and HUVECs, respectively
(Figure 3q).
To demonstrate the 3D tissue sculpting capability of the method, we created multiple layer
3D tissue constructs (Figure 4). In this multilayer fabrication process, after the first layer
fabrication, the lithography process is repeated to create a second and then a third layer
(Figure 4a). In this process, compositions of each element were alternated in different layers
to increase the degree of complexity achievable. With this process, large number of complex
multilayer structures can be fabricated simultaneously (Figure 4b), in various geometries
and architecture (Figure 4c-i), indicating the high throughput potential of this manufacturing
platform. The same system and approach would be simply scaled up in size to achieve
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millions of tissue prototypes. For instance, with a standard 12 inch mask used in the
semiconductor industry, 145 thousand tissue prototypes with an element size of 400 μm and
separation of 400 μm can be fabricated. This number increases to 2.3 million tissue
prototypes with an element size of 100 μm and a separation of 100 μm using the presented
process with a 12 inch mask. Thus, our technology advances the scales of fabrication in
engineering complex tissue architectures.
The multilayer photolithography digital sculpting method presented here utilizes multiple
masks to create individual elements in a tissue construct (Figures S1 and S2). Since the
masks have designated openings to create individual elements in a layer, the cells in an
individual element are exposed to light only once during the fabrication of a layer. On the
other hand, photocrosslinked hydrogels have been commonly used in the literature to
encapsulate various cells, including neural cells,[43] for applications in tissue
engineering.[44,45] Potential effects of UV on cells during the fabrication process of
photocrosslinked materials can be eliminated by replacing the UV light source with a visible
light source and utilizing visible light photoinitiators, such as eosin-Y, triethanolamine, or
camphorquinone as reported earlier.[46–49]
In this work, we have demonstrated the compatibility of our digital tissue sculpting
technology with neural cells. To achieve this, we developed digitally specifiable 3D
hydrogel scaffolds that can be used as neural cell carriers, which supported neural cell
survival and development with a naturalistic ratio of multiple cell-types. The engineered
neural tissue presented here offers new opportunities as a platform technology for 3D in
vitro studies of neural networks. Further, the in situ engineered neural tissue may enable
broad clinical applications for engineering neural implants, providing an important step
forward in transplantation and cell therapy for neural degenerative diseases, as well as
injuries of brain and spinal cord. In combination with optogenetic methods for activating
defined cell types,[50] as well as robotic methods for analyzing single neurons in intact
tissues in an integrative fashion,[51] the described methodologies may open up neural tissue
engineering to the regime of highly accurate 3D architectures capable of exhibiting
naturalistic cell type distributions. With this system, long-term culture studies of neurons
may be performed, which enable gaining insight to neuronal and neurite development in
precisely controlled geometries. Importantly, these new insights and the digitally specifiable
neural tissue could act as testbeds that can lead to disruptive advances such as bioengineered
brain with a natural diversity of neuron types that would enable restoration of brain function
after neurodegeneration, stroke, traumatic brain injury, spinal cord injury, or amyotrophic
lateral sclerosis.
We digitally sculpted multiple cell types in elements within a single tissue prototype in a
high throughput and repeatable manner. This method is based on multilayer
photolithography used in the semiconductor industry and presents great potential to become
a broadly applicable method for high-throughput applications in tissue engineering,
regenerative medicine, and pharmacological studies. This photolithographic approach
enables digital modulation of biological and chemical materials being instantaneously
incorporated into the engineered architecture as a function of time and space allowing
microscale precision without requiring specialized optics or robotics. This advancement
allows us to envision building millions of digitally specified tissue prototypes with
predetermined biomaterials, encapsulated molecules and cell types at complexity and
throughput levels not attained before for in vitro cultures. The developed method would
become a broadly enabling platform for studying cell–cell and cell-matrix inter actions in a
variety of physiologic (e.g., stem cell differentiation) and pathological (e.g., cancer) settings,
in vitro drug screening applications in pharmaceutical industry, and in advanced
biomanufacturing.
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Figure 1.
Digitally specified spatially heterogeneous microfabrication and tissue sculpting. (a) In this
example, the tissue structure is composed of four different types of building blocks, each
with specific cellular and ECM composition shown as different color codes. (b) Fabrication
of 3D multilayer tissue prototypes via a layer-by-layer photomasking and alignment
approach, with a series of photomasks, and a series of hydrogel solutions to be photo
crosslinked to result in digitally sculpted hydrogels (e.g., containing different cell types,
ECM components, and diffusible factors). The simple mask alignment and digital sculpting
device comprises: (i) top cover slip of fabrication compartment, (ii) thickness control spacer,
(iii) a treated glass cover slip on which the sculpted elements are immobilized, (iv)
fabrication chamber, (v) alignment pins, (vi) predesigned photomask and (vii) mask holder
that aligns on the fabrication chamber. Light is applied through the opening in mask holder.
(c-f) Alignment and digital sculpting of individual elements is achieved using a photomask,
which has digitally specified, engineered openings allowing photocrosslinking of tissue
prototypes in a stepwise manner. Fabrication of cubic digitally sculpted blocks is
demonstrated here. Radial circular (g), concentric circular (h) elements can also be sculpted,
mimicking cross-section of embedded vasculature in a tissue construct, where yellow
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hydrogel encapsulates the three types of elements microfabricated as concentric circles. (i)
Digital sculpting approach can also be used to generate complex structures such as
microscale typescript (e.g., BWH, BAMM, HST, and MIT).
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Figure 2.
Digitally specified microfabricated neural tissue. (a) Primary neuron cells were inserted into
100 μm, 200 μm and 500 μm elements enabling visualization of neurite growth and
development. Neurites (anti-Tau-1 staining in green) and nuclei (DAPI staining in blue) of
neurons were observed in neural tissue constructs over 14 days of culture. (b–j) Neurons
were digitally sculpted in 100 μm elements, (k–n) in 200 μm elements, and (o–q) in 500 μm
elements. (r) Quantitative assessment of projected neurite length in digitally sculpted
elements showed different growth dynamics of neurites over time in engineered constructs
with different sizes. Horizontal lines connecting individual groups represent statistically
significant difference and * represents statistically significant difference compared to 1 day
culture (p < 0.05). Error bars represent mean ± STD (n = 3–6). (s) Digital sculpting of 100
μm tissue element next to a 500 μm tissue element, where only the 100 μm element includes
neuron cell bodies. (t) Digitally sculpted array of adjacent 100 μm and 500 μm tissue
prototypes. (u-y) Neuron cells in digitally sculpted 100 μm elements extended neurites into
500 μm elements. (The video in the Supporting Information shows 3D distribution of neuron
cells and the neural circuit formed in digitally sculpted constructs).
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Figure 3.
Immunofluorescent labeling of neurons, glia, excitatory, and inhibitory cells and multicell-
type tissue prototypes generated using digitally specified tissue engineering. (a–c) Anti-
Tau-1 labeled neurons (green), anti-GFAP labeled glial cells (red), and merged image is
shown (DAPI in blue). (d–f) Anti-GAD65 labeled inhibitory neurons (green), anti-CaMKII
labeled excitatory neurons (red), and merged image is shown (DAPI in blue). (g,h) Tau-1-
positive label (green) and CaMKII-positive label (red), and merged image. Scale bars
represent 50 μm of length. Dashed squares represent the borders of digitally specified 3D
neural tissue constructs. (j) Quantitative plot showing the cell type ratio in hydrogels after 3
weeks of culture. Anti-Tau-1 for neurons (63.16 ± 19.92%), anti-GFAP for glia (36.84 ±
19.92%); anti-CaMKII for excitatory neurons (84.20 ± 10.96%), anti-GAD65 for inhibitory
neurons (15.80 ± 10.96%) (n = 4-5). (k) UV light exposure of up to 30 seconds did not
significantly affect neuron cell viability (p > 0.05). (l) Light intensity did not have a
statistically significant effect on neuron cell viability. (m) Neuron viability was observed in
tissue prototypes up to 10 days in culture n = 3–8). (n) Light microscope image of digitally
sculpted radially fractioned circle with three different cell types. (o) Encapsulation of three
cell types (ESCs in green, 3T3 cells in blue, HUVECs in red) in a single tissue prototype
(106 cells/mL for all cell types). Cells were stained using cell tracker dyes to display their
distribution after microfabrication. (p) Encapsulation of three cell types in varying
concentrations using digital sculpting method: ESCs (0.5 × 106 cells/mL), HUVEC (0.75 ×
106 cells/mL) and 3T3 (106 cells/mL). Live/dead stained cells after digital sculpting (green:
live cells, red: nonviable cells). (q) Cells remained highly viable at the end of three day in
vitro culture in digitally specified tissue constructs: 92% (± 5%), 74% (±8%), and 95% (±
3%) for ESCs, and 3T3s, and HUVECs, respectively (n = 3–7). Error bars represent mean ±
STD of the mean. Horizontal lines in the plots (j and k) connecting individual groups
represent statistically significant difference (p < 0.05).
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Figure 4.
Multilayer 3D digitally specified spatially heterogeneous tissue sculpting. (a) Fabrication of
3Dsquare geometry tissue prototypes using multilayer photolithography. (b,c) Micro-
fabricated array of multilayer digitally specified 3D tissue prototypes. (d–g) Side view of 3D
digitally sculpted spatially heterogeneous radial circular tissue construct at different stages
of microfabrication. (h,i) Side view of three layered concentric circular microfabricated
tissue construct.
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